Paydirt
Insider filing · KNSA

Eben Tessari sold $501K of Kiniksa Pharmaceuticals International (KNSA)

Executed Dec 15 2025, disclosed Dec 17 2025, 2 days later.

Value, as filed
$501K
12,048 sh × $41.56
Executed
Dec 15 2025
the trade date, as filed
Disclosed
Dec 17 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
ET Eben Tessari CHIEF OPERATING OFFICER profile →

Eben Tessari (CHIEF OPERATING OFFICER) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $1.6M of KNSA (42,000 sh × $38.33, as filed), executed Sep 29 2025.

The name
KNSA Kiniksa Pharmaceuticals International, plc KNSA · Healthcare · 68 filings in 24 months ticker →

Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Eben Tessari in KNSA
KNSASALE Kiniksa Pharmaceuticals International, plc $488K
11,825 sh × $41.30
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $445K
11,815 sh × $37.65
Exec Oct 14 2025
Filed Oct 16 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $1.6M
42,000 sh × $38.33
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $585K
16,044 sh × $36.45
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $3.5M
98,660 sh across 2 lots
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $536K
15,091 sh × $35.50
Exec Sep 3 2025
Filed Sep 3 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $544K
16,100 sh × $33.77
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $4.6M
138,064 sh × $33.20
Exec Aug 5 2025
Filed Aug 7 2025 · 5:30 PM ET